| 000 | 01060 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250517215213.0 | ||
| 264 | 0 | _c20190412 | |
| 008 | 201904s 0 0 eng d | ||
| 022 | _a1619-7089 | ||
| 024 | 7 |
_a10.1007/s00259-018-4049-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLaffon, Eric | |
| 245 | 0 | 0 |
_aOptimal method for measuring baseline metabolic tumor volume in DLBCL patients: are statistical agreements of SUV ≥2.5 satisfactory? _h[electronic resource] |
| 260 |
_bEuropean journal of nuclear medicine and molecular imaging _c09 2018 |
||
| 300 |
_a1832-1833 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aFluorodeoxyglucose F18 |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLymphoma, Large B-Cell, Diffuse |
| 650 | 0 | 4 | _aTumor Burden |
| 700 | 1 | _aMarthan, Roger | |
| 773 | 0 |
_tEuropean journal of nuclear medicine and molecular imaging _gvol. 45 _gno. 10 _gp. 1832-1833 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00259-018-4049-5 _zAvailable from publisher's website |
| 999 |
_c28400575 _d28400575 |
||